FDA finalizes guidance on charging for investigational drugs
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyClinical TrialsPharmaceuticalsProduct developmentResearch, Design and DevelopmentUnited StatesRegulatory NewsJoanne S. EglovitchBiologics/ biosimilars/ vaccinesBiotechnologyClinical TrialsPharmaceuticalsProduct developmentResearch, Design and DevelopmentUnited States